FDA Inspection 1074990 — Heinz-Josef Klumpen, MD

Heinz-Josef Klumpen, MD — FEI 3014498913

The FDA completed an inspection of Heinz-Josef Klumpen, MD on Oct 12, 2018 in Amsterdam. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Oct 12, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Amsterdam (Netherlands)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.